< Back to companies

Syneos Health

Drug development built on outcomes

Morrisville, North Carolina, US

Syneos Health is a fully integrated biopharmaceutical solutions organization providing contract research and commercial services. The company was taken private in September 2023 for a $4.46 billion equity value and boasts a global workforce of over 26,000 employees. They have played a significant role in the development and commercialization of a high percentage of FDA-approved novel drugs and EMA-authorized products.

Share
Shareable draft
Get Involved in Syneos Health

How We Help

Problem Statement

Bringing new health treatments to market efficiently by providing integrated services for late-stage clinical trials and commercialization.

Core Technology

Clinical trial management and commercialization services infrastructure

Key Differentiators

Integrated clinical research (CRO) and commercialization services

Clinical Focus

Clinical Trials; Drug Development

Company Info

Business Model
B2B
Website
www.syneoshealth.com

Categories

Drug Discovery/Development

Disease Areas

Technologies

Contract Research Organization (CRO)Clinical TrialsPharmaceutical ServicesBiotechnology

Clinical & IP

🔬

Clinical Validation

93% involvement in novel FDA-approved drugs; 96% of oncology drug approvals; 89% of CNS medications. Leading decentralized trial capabilities through partnerships including Medable for technology integration.

Only accessible to MedStartr community members. Join now

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Sign in to join the conversation.

Sign in to comment
Be the first to comment.

What do you think of Syneos Health?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Your scores and comments are shown with your review on this company's profile.

Get Involved in Syneos Health
💬

Hi, I'm Syggy!

MedStartr's AI healthcare innovation superhero. Just click me for whatever you need! 🥰

💬
Hi, I'm Syggy
your healthcare innovation buddy
💬

Ask Syggy anything

What MedStartr is, how it can help you, events, joining...

You're chatting as a visitor: this conversation stays in this browser, isn't linked to any account, and doesn't move over if you join. Join free